Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Vulvar Lichen Sclerosus
NCT03045172Completed
- Sponsor
- The Centers for Vulvovaginal Disorders
- Start
- Nov 2016
- Primary completion
- Aug 2018
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, double-blind trial in vulvar lichen sclerosus (LS) comparing PRP Group with Placebo Group (2 arms). Primary endpoint: Inflammatory Infiltration on Biopsy Specimens at 14 weeks. Started Nov 2016; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT03045172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03045172.